Link

May 2018

“OncoRACT” – The First Therapy Specific RACT for Clinical Trials

By |2020-09-23T10:54:27+02:00May 1, 2018|Neat Features, News, RBQM Product Updates|Comments Off on “OncoRACT” – The First Therapy Specific RACT for Clinical Trials

Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.

Mar 2018

Blockchain in Clinical Trials – The Ultimate Data Notary

By |2022-12-02T14:45:07+02:00March 14, 2018|Free White Papers, News|Comments Off on Blockchain in Clinical Trials – The Ultimate Data Notary

Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.

Feb 2018

Webinar | Best Practices in Defining KRIs for Clinical Trials

By |2020-09-23T10:04:26+02:00February 13, 2018|News|Comments Off on Webinar | Best Practices in Defining KRIs for Clinical Trials

Are your role connected with the controlling the quality, performance or risks of clinical trials? We are delighted to invite you along to this exclusive live webinar and Q&A session on February 23rd, 2018.

Jan 2018

Newsletter: Fast-advancing science has opened the era of personalized medicine

By |2018-01-02T08:37:06+02:00January 2, 2018|News|Comments Off on Newsletter: Fast-advancing science has opened the era of personalized medicine

More than ever before, well-designed clinical trials are essential to maximize chances of success.

Dec 2017

Newsletter: Start 2018 with an easier way to manage your clinical risks

By |2017-12-13T13:58:18+02:00December 11, 2017|News|Comments Off on Newsletter: Start 2018 with an easier way to manage your clinical risks

100% SDV...seriously, who DOES this? Start 2018 with an easier way to manage your clinical risks.

Jan 2014

Risk Reduction in Clinical Trials for Pharmaceutical Organizations

By |2016-06-11T12:11:36+02:00January 20, 2014|News|Comments Off on Risk Reduction in Clinical Trials for Pharmaceutical Organizations

The software solution EarlyBird targets data anomalies on the early stages of the clinical trials and increases the data quality. High clinical data quality reduces monitoring costs, secures the FDA/EMA approval with higher resolution of the clinical effect.

Go to Top